Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ginkgoselect Phytosome

This article was originally published in The Tan Sheet

Executive Summary

Ginkgo extract complex with soy phospholipids demonstrates superior bioavailability and improved antioxidant action relative to a standard extract, Indena researchers report at a symposium during the American Society of Pharmacognosy annual meeting in Seattle July 23. The Italian firm maintains the complex is well-tolerated in rats and does not interfere with primary haemostasis at pharmacologically active doses. The compound is a good candidate for future, long-term clinical trials at reduced doses, Indena suggests. The company specializes in the extraction of plant-based active substances for the pharmaceutical, cosmetic and dietary supplement industries
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel